However, when comparing the potency of CD30-directed CAR-T cells against CD30+ HSPCs and CD30+ MyLa cutaneous T cell lymphoma cells [27], minimal activity was observed against the former. Here, TNFRSF8 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.